Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 23.6126.5119.2419.0315.10

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 23.61 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202523.61
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2025 23.61
-10.94
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹430,638.4 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics
MANKIND PHARMA ₹83,401.6 Cr 1% -1.3% -11.5% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

2.9%

3.6%

0.2%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses